

HY-121600 · 1 mg
MedChemExpress · Cat: HY-121600
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/gat229.htmlDescription
GAT229 is a CB1 positive allosteric modulator PAM that effectively reduces intraocular pressure IOP in high IOP mouse models and enhances CB1 receptor-mediated IOP-lowering effects. A 0.2 % GAT229 solution or 10 mg/kg of GAT229 alone significantly reduces IOP. GAT229 is promising for research related to glaucoma and elevated intraocular pressure.







